Patient and healthcare provider experiences of hepatitis C treatment with direct-acting antivirals in Rwanda: a qualitative exploration of barriers and facilitators

BACKGROUND: Direct-acting antivirals (DAAs) are increasingly accessible to patients with hepatitis C (HCV) worldwide and are being introduced through national health systems in sub-Saharan Africa. DAAs are highly efficacious when tested in controlled trials, yet patients treated outside of study set...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Public Health
Auteurs principaux: Serumondo, Janvier, Penkunas, Michael J., Niyikora, Julienne, Ngwije, Alida, Kiromera, Athanase, Musabeyezu, Emmanuel, Umutesi, Justine, Umuraza, Sabine, Musengimana, Gentille, Nsanzimana, Sabin
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2020
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7298738/
https://ncbi.nlm.nih.gov/pubmed/32546216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12889-020-09000-0
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires